Abstract
Neuroendocrine small cell carcinoma of the bladder is a rare cancer, rapidly aggressive and metastatic with a very pejorative behavior. The diagnosis is based on histological analysis coupled with immunohistochemical study. Because it is rare, there is no consensus to date. Its management should be multidisciplinary, involving surgery, chemotherapy, and radiotherapy. We report two new cases of neuroendocrine small cell carcinoma of the bladder, one is pure and the other associated with urothelial carcinoma. The poor outcome illustrates the quick evolution of this tumor. A review of the literature on this topic is also presented.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
